Beckman Coulter Selects Fisher Biosciences Unit, Cellomics, to Provide Ongoing Service for HCS Customers |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Cellomics, Inc.
100 Technology Drive
Pittsburgh, PA, 15219
USA
Press release date: June 13, 2006
PITTSBURGH, June 13, 2006-Cellomics, the creator of and world leader in high content screening (HCS) and a unit of Fisher Biosciences, announced today that it has reached an agreement to provide maintenance and service support to HCS customers of Beckman Coulter Inc. This agreement covers the Beckman Coulter Cell Lab IC 100 Image Cytometer and the EIDAQ 100 High-Throughput Microscopy System. Beckman Coulter recently announced that it would no longer market these products but would continue to support existing customers. "Our primary goal in reaching this agreement was to provide ongoing support for our customers," said Karen Bezold, director of Research Cytometry, Beckman Coulter, Inc. "With Cellomics' expertise in the HCS field, we are confident our customers will have the best possible support going forward." Beckman Coulter will continue to focus its research cytometry business on flow cytometry and particle characterization, where the company has considerable history, technology and expertise. Cellomics specializes in complete cellular analysis systems, including automated imaging hardware, image analysis software, informatics and reagents. "Our agreement with Beckman Coulter is an affirmation of Cellomics' technology leadership and service excellence," said Ron Lowy, president and chief executive officer of Fisher Biosciences. "We have the expertise to answer virtually any question concerning HCS and help customers solve any technical problems they may encounter. We are excited about the opportunity to serve another group of customers who are interested in HCS technology." About Cellomics Cellomics, a business unit within the Fisher Biosciences group, provides complete systems for High Content Screening (HCS) and Analysis (HCA) to drug discovery and systems biology researchers. The Cellomics platform includes automated imaging instrumentation (ArrayScan® and KineticScan® HCS Readers and the cellWoRxTM High Content Cell Analysis System), BioApplication image analysis software, High Content Informatics (HCiTM), and HitKit® HCS Reagent Kits, fully integrated to improve the quality and productivity of cell-based assays. Cellomics' proprietary platforms are in use at multiple sites within the top 15 pharmaceutical companies, as well as leading biotechnology companies and academic centers throughout the world. For more information about Cellomics-brand products and services, please visit www.cellomics.com or call 412-770-2200. About Fisher Biosciences Fisher Biosciences, a unit of Fisher Scientific International Inc., manufactures and supplies a wide range of products and services across the general-chemistry and life-sciences arenas. From fine and high-purity chemicals, clinical diagnostics, proprietary protein-research and cell-culture products, and sterile-liquid-handling systems, to innovative RNA-interference technology and high content screening, Fisher Biosciences serves scientific-research, healthcare, drug-discovery, and general industrial customers around the world. Additional information about Fisher Biosciences is available online at fisherbiosci.com. About Beckman Coulter Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum - from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing - Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance healthcare around the world. The company, based in Fullerton, California, reported 2005 annual sales of $2.44 billion. For more information, visit www.beckmancoulter.com.
Media Contact: Judy P. Masucci, Ph.D. Director of Marketing Cellomics, Inc. (412) 770-2353 E-Mail: pr@cellomics.com
|
|
|
|
|
|
|
|
|
|
|
| 
